Combining siRNA and AAV therapy approaches to target human basal-like breast cancer: from vector development to anti-tumor efficacy evaluation
Team
Sponsor
FCT
Dates and Lifetime
From: 2013-07-01 To: 2015-12-31
Duration: 30 months
Reference
PTDC/BBB-BIO/1240/2012
Code
IBET